A Post Marketing Surveillance Study To Determine The Safety, Tolerability And Effectiveness Of Doxazosin Mesylate GITS Among Filipino Adult Males With Benign Prostatic Hyperplasia (BPH).
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2011
At a glance
- Drugs Doxazosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Adverse reactions
- Sponsors Pfizer
- 09 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 02 Aug 2010 Planned end date changed from 1 Dec 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.